Form 4: Hims & Hers Chief Legal Officer Executes Planned Stock Sale
Insider Transaction Report
Soleil Boughton, Chief Legal Officer of Hims & Hers Health, Inc., sold 2,572 shares of Class A Common Stock on July 14, 2025, at $47.82 per share, as part of a pre-arranged Rule 10b5-1 trading plan.
Summary
- Soleil Boughton, Chief Legal Officer of Hims & Hers Health, Inc. (HIMS), reported a sale of company stock.
- The transaction involved the disposition of 2,572 shares of Class A Common Stock.
- The shares were sold at a price of $47.82 per share.
- The sale occurred on July 14, 2025.
- Following this transaction, Soleil Boughton beneficially owns 158,165 shares of Class A Common Stock.
- The sale was executed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 28, 2024.
Sentiment
Score: 6
Explanation: The sentiment is neutral to slightly positive. While it's an insider sale, the fact that it was conducted under a Rule 10b5-1 plan mitigates potential negative interpretations, indicating a pre-scheduled, non-discretionary transaction rather than a reaction to new information.
Positives
- The sale was conducted under a Rule 10b5-1 trading plan, indicating a pre-scheduled transaction designed to comply with insider trading regulations and reduce concerns about opportunistic selling.
Negatives
- An insider sale, even if pre-planned, represents a reduction in direct ownership by a key executive.
Risks
- While the sale is pre-planned, significant or repeated insider selling could potentially be interpreted by investors as a lack of confidence in future stock performance, though this specific transaction is small relative to total holdings.
Future Outlook
NA
Industry Context
This insider transaction is specific to Hims & Hers Health, Inc. and does not directly reflect broader industry trends. Such routine sales under Rule 10b5-1 plans are common across various industries for executive compensation and financial planning.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Insider Trading Plan Disclosure | The sale was conducted under a Rule 10b5-1 trading plan, adopted on August 28, 2024, which is a corporate governance mechanism allowing insiders to sell shares without being accused of trading on material non-public information. | 07/14/2025 | Enhances transparency and compliance regarding insider stock transactions, reducing potential for market manipulation concerns. |
Stakeholder Impact
- Shareholders: May observe the reduction in direct ownership by a key executive, though the pre-planned nature of the sale under Rule 10b5-1 typically lessens concerns.
Key Dates
| Date | Description |
|---|---|
| 08/28/2024 | Date the Rule 10b5-1 trading plan was adopted by Soleil Boughton. |
| 07/14/2025 | Date of the reported transaction (sale of Class A Common Stock). |
| 07/15/2025 | Date the Form 4 was signed by the attorney-in-fact. |
Recommendation
holdKeywords
Hims & Hers, HIMS, Soleil Boughton, Chief Legal Officer, Insider Trading, Form 4, Stock Sale, Rule 10b5-1, Equity Transaction, Corporate Governance
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.